NCT06914622 (EMPOWER-RES) is a NA clinical trial of Mental Health Recovery Star (MHRS) in Severe Mental Disorder, sponsored by IRCCS Centro San Giovanni di Dio Fatebenefratelli.

Who is sponsoring NCT06914622?

NCT06914622 is sponsored by IRCCS Centro San Giovanni di Dio Fatebenefratelli.

What drugs are being tested in NCT06914622?

Interventions in NCT06914622: Mental Health Recovery Star (MHRS).

What condition does NCT06914622 study?

NCT06914622 studies Severe Mental Disorder, Severe Mental Illness.

Is NCT06914622 still recruiting?

NCT06914622 is currently recruiting now. Last updated 18 December 2025.

Last reviewed 2025-12-18 · How we verify

NCT06914622: EMPOWER-RES

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Real-time Experiences, Physical Activity and Biological Outcomes in Personal Recovery Residents (EMPOWER-RES)

Recruiting now NA Last updated 18 December 2025

What this trial tests

NA trial testing Mental Health Recovery Star (MHRS) in Severe Mental Disorder in 72 participants. Currently enrolling.

Timeline

15 January 2026

Primary endpoint
31 December 2027

31 December 2028

Quick facts

Lead sponsor	IRCCS Centro San Giovanni di Dio Fatebenefratelli
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	72
Start date	15 January 2026
Primary completion	31 December 2027
Estimated completion	31 December 2028
Sites	3 locations across Italy

Drugs / interventions tested

Mental Health Recovery Star (MHRS)

Conditions studied

Severe Mental Disorder — all drugs for Severe Mental Disorder →
Severe Mental Illness — all drugs for Severe Mental Illness →

Sponsor

IRCCS Centro San Giovanni di Dio Fatebenefratelli

Who can join

18 and older, any sex, with Severe Mental Disorder or Severe Mental Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The project focuses on patients with severe mental disorders (SMD) residing in Italian mental health supported accommodation (SA). Although the goal of SA is to promote personal recovery - that is, living life to the fullest of one's potential - international literature on this topic is scarce, and traditional treatments in the Italian residential system show limitations in adopting such approaches. The research hypothesis is that activating personal recovery pathways could improve the biopsychosocial outcomes of patients, caregivers, and professionals. To test this hypothesis, a non-pharmacological, non-randomized interventional trial will compare two groups: one group of individuals with SMD receiving recovery-oriented treatment, using the Mental Health Recovery Star, and another group of individuals with SMD receiving standard treatment. The Mental Health Recovery Star is a ten-pointed star-shaped tool that represents various life dimensions. Patients, together with their key professional, are expected to negotiate a score for each domain on the five-stage 'Scale of Change,' capturing and monitoring the different phases of the recovery process.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Severe Mental Disorder

Currently open trials in the same condition.

NCT07470346 — Musical Intervention for the Management of Anxiety and Stress in People With Severe Mental Disorder in a Medium-stay Uni · NA · active not recruiting
NCT07085923 — Norwegian Mental Illness Heart Health Study · NA · recruiting
NCT06628011 — Digital Follow-up of Aerobic Interval Training in Outpatients With Mental Disorders · NA · recruiting
NCT05533749 — Evaluating the Effectiveness of the GILL eHealth Intervention to Improve Physical Health and Lifestyle Behaviours in Pat · NA · recruiting
NCT06904079 — Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Anal · NA · recruiting

Other IRCCS Centro San Giovanni di Dio Fatebenefratelli trials

Trials by the same sponsor.

NCT07497347 — Effects of Specific Amino Acid Supplementation and Lifestyle Factors on Brain Ageing · NA · recruiting
NCT06989944 — Physical Activity-based Intervention in Depressed Patients: Clinical, Neurophysiological, Epigenetic and Metabolic Corre · NA · active not recruiting
NCT06657274 — EARLY-COGN^3 - Smart Digital Solutions for EARLY Treatment of COGnitive Disability: a Neuropsychological, Neurophysiolog · NA · recruiting
NCT06461104 — Physical Activity in People With Borderline Personality Disorder (PABORD) · NA · not yet recruiting
NCT06702215 — Cortical Plasticity of the Tactile Mirror System in Borderline Personality Disorder · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06914622 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS Centro San Giovanni di Dio Fatebenefratelli
Last refreshed: 18 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06914622.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing